These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15962431)

  • 41. British HIV Association and Children's HIV Association guidelines for the management of HIV infection in pregnant women 2008.
    de Ruiter A; Mercey D; Anderson J; Chakraborty R; Clayden P; Foster G; Gilling-Smith C; Hawkins D; Low-Beer N; Lyall H; O'Shea S; Penn Z; Short J; Smith R; Sonecha S; Tookey P; Wood C; Taylor G
    HIV Med; 2008 Aug; 9(7):452-502. PubMed ID: 18840151
    [No Abstract]   [Full Text] [Related]  

  • 42. CDC releases detailed guidelines for PEP use. Agency focuses on nonoccupational exposure.
    AIDS Alert; 2005 Apr; 20(4):42-4. PubMed ID: 15841527
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Guidelines: opportunistic infections and HIV patients.
    Winslow DL
    AIDS Alert; 2009 Jul; 24(7):81. PubMed ID: 19705577
    [No Abstract]   [Full Text] [Related]  

  • 44. CD4 count and viral load time-courses in patients treated with highly active antiretroviral therapy and association with the CDC staging system.
    Collazos J; Knobel H; Casado JL;
    HIV Med; 2006 Nov; 7(8):504-13. PubMed ID: 17105509
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Opportunistic infections update.
    Proj Inf Perspect; 1999 Sep; (28):11-3. PubMed ID: 11367355
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antiretroviral therapy: practice guidelines and National ART Programme.
    Bachani D; Rewari BB
    J Indian Med Assoc; 2009 May; 107(5):308, 310-4, 316 passim. PubMed ID: 19886386
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Usefulness of an observational database to assess antiretroviral treatment trends in India.
    Cecelia AJ; Christybai P; Anand S; Jayakumar K; Gurunathan T; Vidya P; Solomon S; Kumarasamy N
    Natl Med J India; 2006; 19(1):14-7. PubMed ID: 16570679
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection.
    Chiappini E; Galli L; Tovo PA; Gabiano C; Gattinara GC; Guarino A; Badolato R; Giaquinto C; Lisi C; de Martino M;
    AIDS; 2006 Jan; 20(2):207-15. PubMed ID: 16511413
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevention of tuberculosis in HIV-infected patients.
    Nahid P; Daley CL
    Curr Opin Infect Dis; 2006 Apr; 19(2):189-93. PubMed ID: 16514345
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Seek and treat: HIV update 2011.
    Taege A
    Cleve Clin J Med; 2011 Feb; 78(2):95-100. PubMed ID: 21285341
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Complications of HIV disease and antiretroviral therapy.
    Currier JS; Havlir DV
    Top HIV Med; 2009; 17(2):57-67. PubMed ID: 19401608
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 4-year update. CDC rewrites treatment guidelines, pushes for more public awareness.
    AIDS Policy Law; 2006 Aug; 21(16):1, 4. PubMed ID: 17230632
    [No Abstract]   [Full Text] [Related]  

  • 53. Initial antiretroviral drugs.
    Rojo P; Gonzalez-Tome MI; Ramos JT
    Pediatr Infect Dis J; 2007 Dec; 26(12):1167; author reply 1167. PubMed ID: 18043466
    [No Abstract]   [Full Text] [Related]  

  • 54. Circulating memory B-cell subpopulations are affected differently by HIV infection and antiretroviral therapy.
    D'Orsogna LJ; Krueger RG; McKinnon EJ; French MA
    AIDS; 2007 Aug; 21(13):1747-52. PubMed ID: 17690573
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Special report: federal AIDS prevention funding at risk. 1992 CDC guidelines spell out dos and don'ts.
    AIDS Alert; 2002 Mar; 17(3):39-40. PubMed ID: 12206095
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Revised guideline "Antiretroviral Treatment"].
    Werkgroep antiretrovirale behandeling van de Nederlandse Vereniging van Aids Behandelaren
    Ned Tijdschr Geneeskd; 2005 Oct; 149(43):2399-405. PubMed ID: 16277129
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The data continue to support early ART . . . and now the guidelines do, too. In late 2009, both the DHHS and WHO guidelines raised the CD-4-cell-count threshold for starting treatment.
    Zuger A
    J Watch AIDS Clin Care; 2010 Jan; 22(1):1-2. PubMed ID: 20617573
    [No Abstract]   [Full Text] [Related]  

  • 58. Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.
    Skiest DJ; Su Z; Havlir DV; Robertson KR; Coombs RW; Cain P; Peterson T; Krambrink A; Jahed N; McMahon D; Margolis DM;
    J Infect Dis; 2007 May; 195(10):1426-36. PubMed ID: 17436222
    [TBL] [Abstract][Full Text] [Related]  

  • 59. There's nothing routine about HIV. CDC's recommendations for HIV testing.
    Sharp M
    Posit Aware; 2007; 18(2):14. PubMed ID: 17390483
    [No Abstract]   [Full Text] [Related]  

  • 60. FDA notifications. New antiretroviral guidelines issued.
    AIDS Alert; 2005 Jan; 20(1):11-2. PubMed ID: 15717358
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.